- Home
- GERN vs PRSU Comparison
GERN vs PRSU Comparison
Compare GERN & PRSU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- PRSU
- Stock Information
- Founded
- GERN 1990
- PRSU 1926
- Country
- GERN United States
- PRSU United States
- Employees
- GERN N/A
- PRSU N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- PRSU Business Services
- Sector
- GERN Health Care
- PRSU Consumer Discretionary
- Exchange
- GERN Nasdaq
- PRSU Nasdaq
- Market Cap
- GERN 878.9M
- PRSU 914.6M
- IPO Year
- GERN 1996
- PRSU N/A
- Fundamental
- Price
- GERN $1.27
- PRSU $30.38
- Analyst Decision
- GERN Buy
- PRSU Buy
- Analyst Count
- GERN 11
- PRSU 1
- Target Price
- GERN $5.80
- PRSU $50.00
- AVG Volume (30 Days)
- GERN 15.1M
- PRSU 289.7K
- Earning Date
- GERN 05-07-2025
- PRSU 05-08-2025
- Dividend Yield
- GERN N/A
- PRSU N/A
- EPS Growth
- GERN N/A
- PRSU 4203.05
- EPS
- GERN N/A
- PRSU 12.84
- Revenue
- GERN $76,994,000.00
- PRSU $366,488,000.00
- Revenue This Year
- GERN $208.83
- PRSU $13.73
- Revenue Next Year
- GERN $57.49
- PRSU $6.52
- P/E Ratio
- GERN N/A
- PRSU $3.11
- Revenue Growth
- GERN 32386.92
- PRSU 4.63
- 52 Week Low
- GERN $1.19
- PRSU $29.13
- 52 Week High
- GERN $5.34
- PRSU $47.49
- Technical
- Relative Strength Index (RSI)
- GERN 34.43
- PRSU N/A
- Support Level
- GERN $1.17
- PRSU N/A
- Resistance Level
- GERN $1.39
- PRSU N/A
- Average True Range (ATR)
- GERN 0.13
- PRSU 0.00
- MACD
- GERN 0.01
- PRSU 0.00
- Stochastic Oscillator
- GERN 21.74
- PRSU 0.00
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About PRSU Pursuit Attractions and Hospitality Inc. Common Stock
Pursuit Attractions and Hospitality Inc is an attractions and hospitality company that owns and operates a collection of inspiring and unforgettable experiences in iconic destinations in the United States, Canada, and Iceland. Its elevated hospitality experiences include point-of-interest attractions and distinctive lodges, along with integrated restaurants, retail, and transportation that enable visitors to discover and connect with stunning national parks and renowned travel locations.